Depletion of resuscitation-promoting factors has limited impact on the drug susceptibility of Mycobacterium tuberculosis

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 8, 2010, Pages 1583-1585

  Kana, Bavesh D ^a   Mizrahi, Valerie ^a   Gordhan, Bhavna G ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Antibiotics; Dormancy; Muralytic; Peptidoglycan; Rpf

Indexed keywords

CARBENICILLIN; CERULENIN; CHLORPROMAZINE; ERYTHROMYCIN; PEPTIDOGLYCAN; RIFAMPICIN; VANCOMYCIN; BACTERIAL PROTEIN; CYTOKINE; RESUSCITATION-PROMOTING FACTOR, BACTERIA; TUBERCULOSTATIC AGENT;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BROTH DILUTION; DRUG SENSITIVITY; GENOTYPE; IN VITRO STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; DEFICIENCY; DRUG EFFECTS; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; PROCEDURES;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CYTOKINES; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; VANCOMYCIN;

EID: 77954717657     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq199     Document Type: Article

References (12)

1. Kana BD, Mizrahi V. Resuscitation-promoting factors as lytic enzymes for bacterial growth and signaling. FEMS Immunol Med Microbiol 2010; 58: 39-50.
2. Kana BD, Gordhan BG, Downing KJ et al. The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol Microbiol 2008; 67: 672-84.
3. Mukamolova GV, Turapov O, Malkin J et al. Resuscitation-promoting factors reveal an occult population of tubercle bacilli in sputum. Am J Respir Crit Care Med 2009; 181: 174-80.
4. Demina GR, Makarov VA, Nikitushkin VD et al. Finding of the low molecular weight inhibitors of resuscitation promoting factor enzymatic and resuscitation activity. PLoS One 2009; 4: e8174.
5. Hett EC, Chao MC, Steyn AJ et al. A partner for the resuscitation-promoting factors of Mycobacterium tuberculosis. Mol Microbiol 2007; 66: 658-68.
6. Hett EC, Rubin EJ. Bacterial growth and cell division: a mycobacterial perspective. Microbiol Mol Biol Rev 2008; 72: 126-56.
7. Downing KJ, Mischenko VV, Shleeva MO et al. Mutants of Mycobacterium tuberculosis lacking three of the five rpf-like genes are defective for growth in vivo and for resuscitation in vitro. Infect Immun 2005; 73: 3038-43.
8. Domenech P, Reed MB, Barry CE III. Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance. Infect Immun 2005; 73: 3492-501.
9. Hett EC, Chao MC, Deng LL et al. A mycobacterial enzyme essential for cell division synergizes with resuscitation-promoting factor. PLoS Pathog 2008; 4: e1000001.
10. Vandal OH, Roberts JA, Odaira T et al. Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment. J Bacteriol 2009; 191: 625-31.
11. Korsak D, Liebscher S, Vollmer W. Susceptibility to antibiotics and β-lactamase induction in murein hydrolase mutants of Escherichia coli. Antimicrob Agents Chemother 2005; 49: 1404-9.
12. Heidrich C, Ursinus A, Berger J et al. Effects of multiple deletions of murein hydrolases on viability, septum cleavage, and sensitivity to large toxic molecules in Escherichia coli. J Bacteriol 2002; 184: 6093-9.